Published by Josh White on 17th June 2022
(Sharecast News) - Cancer therapeutics and women's health-focussed ValiRx updated the market on its proposed sub-licensing agreement with TheoremRx for 'VAL201' on Friday.
URL: http://www.digitallook.com/dl/news/story/32758040/...